Machine learning identifies disease-specific signatures in organoids derived from schizophrenia and bipolar disorder patients.

The software also detected the ‘sequence effect’ in both iRBD and Parkinson’s patients—a progressive decline in movement speed and amplitude during repetitive actions. This effect could serve as an ...

Medtronic (NYSE: MDT) today announced study results backing its adaptive DBS algorithm for personalized therapy in ...

Neurodegenerative diseases—such as Alzheimer’s, Parkinson’s, Huntington’s, and ALS—are progressive disorders characterized by the loss of structure and ...

It feels like everywhere you look these days, AI is being talked about, and healthcare is no exception. We’re seeing a lot of discussion about how artificial intelligence could really change how ...